MS On Lupin
OW, TP Rs 1003
Co Announced Out-licensing Deal With Boehringher Ingelheim (BI) For Oncology Drugs
Estimate 6-7 Yrs To Commercialise These Assets Assuming Successful Clinical/Regulatory Dvpts
Feedback
LUPIN 
Reputation: 13,324 • Sep 5, 2019 12:59 PM
Vote
Comment
Share